drugset / Trial / NCT01991821
European Phase III Study of APD421 in PONV
RandomizedParallel-groupQuadruple-blindPrevention
Summary
A comparison of the efficacy of APD421 and placebo in the prevention of PONV in patients at moderate-to-high risk of PONV.
Timeline
- Start
- 2013-07
- Primary completion
- 2014-01
- Completion
- 2014-01
Outcome
Missed primary endpoint
registry analysis (superiority test); APD421 vs Placebo; p = 0.093; Chi-squared, Corrected NCT01991821 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amisulpride | Small molecule | — | Intravenous |
Indications
No indication recorded.